Evidence map›Paper›PMID 30965558›Full record

ArticleInternational journal of molecular sciences2019

Targeted Capture of Chinese Hamster Ovary Host Cell Proteins: Peptide Ligand Discovery.

R Ashton Lavoie, Alice di Fazio, R Kevin Blackburn, Michael B Goshe, Ruben G Carbonell, Stefano Menegatti

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Analytical Tools for HCP Detection, Identification, and Quantitation.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Affibody-Binding Ligands.International journal of molecular sciences · 2020
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

R Ashton LavoieDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC 27695-7905, USA. rabradl3@ncsu.edu.ORCID 0000-0001-9842-8520
Alice di FazioDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC 27695-7905, USA. abdifazi@ncsu.edu.
R Kevin BlackburnDepartment of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, NC 27695-7622, USA. Kevin_Blackburn@waters.com.
Michael B GosheDepartment of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, NC 27695-7622, USA. mbgoshe@ncsu.edu.
Ruben G CarbonellDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC 27695-7905, USA. ruben@ncsu.edu.
Stefano MenegattiDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC 27695-7905, USA. smenega@ncsu.edu.
North Carolina State University · US

Funding

Kenan Institute for Engineering, Technology and Science N/ANational Science Foundation DBI-0619250National Science Foundation DBI-1126244
6 · The paper itself

Abstract

The growing integration of quality-by-design (QbD) concepts in biomanufacturing calls for a detailed and quantitative knowledge of the profile of impurities and their impact on the product safety and efficacy. Particularly valuable is the determination of the residual level of host cell proteins (HCPs) secreted, together with the product of interest, by the recombinant cells utilized for production. Though often referred to as a single impurity, HCPs comprise a variety of species with diverse abundance, size, function, and composition. The clearance of these impurities is a complex issue due to their cell line to cell line, product-to-product, and batch-to-batch variations. Improvements in HCP monitoring through proteomic-based methods have led to identification of a subset of "problematic" HCPs that are particularly challenging to remove, both at the product capture and product polishing steps, and compromise product stability and safety even at trace concentrations. This paper describes the development of synthetic peptide ligands capable of capturing a broad spectrum of Chinese hamster ovary (CHO) HCPs with a combination of peptide species that allow for advanced mixed-mode binding. Solid phase peptide libraries were screened for identification and characterization of peptides that capture CHO HCPs while showing minimal binding of human IgG, utilized here as a model product. Tetrameric and hexameric ligands featuring either multipolar or hydrophobic/positive amino acid compositions were found to be the most effective. Tetrameric multipolar ligands exhibited the highest targeted binding ratio (ratio of HCP clearance over IgG loss), more than double that of commercial mixed-mode and anion exchange resins utilized by industry for IgG polishing. All peptide resins tested showed preferential binding to HCPs compared to IgG, indicating potential uses in flow-through mode or weak-partitioning-mode chromatography.

Indexed as

AnimalsCHO CellsChromatography, AffinityChromatography, LiquidCricetinaeCricetulusHumansPeptidesProteomicsPeptideshost cell proteinspeptide ligandsprotein purificationtherapeutic antibodies

Identifiers

PMID30965558
PMCPMC6479451
OpenAlexW2933369432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.